These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26152414)

  • 1. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
    Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
    Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on.
    Fok E; Jacsó O; Szebeni Z; Gyorffy A; Sükösd L; Lukács Z; Schaper R
    Parasitol Res; 2010 Apr; 106(5):1141-9. PubMed ID: 20165873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
    Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
    Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
    Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
    Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs.
    Traversa D; Aste G; Di Cesare A; Paoletti B; Di Tommaso M; Di Giulio E; Pampurini F; Tunesi C; Boari A
    Vet Parasitol; 2011 Jun; 179(1-3):107-12. PubMed ID: 21435791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
    Bowman DD; Charles SD; Arther RG; Settje T
    Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
    McCall JW; Arther R; Davis W; Settje T
    Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
    Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
    Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
    Genchi M; Vismarra A; Lucchetti C; Viglietti A; Crosara S; Gnudi G; Quintavalla C; Schaper R; Kramer L
    Vet Parasitol; 2019 Sep; 273():11-16. PubMed ID: 31442887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic dermatitis by Dirofilaria repens in a dog: clinical picture and treatment.
    Rocconi F; Di Tommaso M; Traversa D; Palmieri C; Pampurini F; Boari A
    Parasitol Res; 2012 Jul; 111(1):493-6. PubMed ID: 22290449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heartworm control in Grenada, West Indies: Results of a field study using imidacloprid 10% + moxidectin 2.5% and doxycycline for naturally-acquired Dirofilaria immitis infections.
    Paterson T; Fernandez C; Burnett PJ; Lessey L; Hockley T; Hagen R; Coomansingh C; Sharma B; Chandrashekar R; Schaper R
    Vet Parasitol; 2020 Aug; 284():109194. PubMed ID: 32866837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi® administration on immature adult parasites.
    Chandrashekar R; Beall MJ; Saucier J; O'Connor T; McCall JW; McCall SD
    Vet Parasitol; 2014 Nov; 206(1-2):93-8. PubMed ID: 25218886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of a topically applied imidacloprid 10 % / moxidectin 2.5 % formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi worms in experimentally infected dogs.
    Austin CM; Kok DJ; Crafford D; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():91-108. PubMed ID: 23779222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis).
    Arther RG; Atkins C; Ciszewski DK; Davis WL; Ensley SM; Settje TL
    Parasitol Res; 2005 Oct; 97 Suppl 1():S70-S75. PubMed ID: 16228278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs.
    Genchi M; Pengo G; Genchi C
    Vet Parasitol; 2010 May; 170(1-2):167-9. PubMed ID: 20193980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
    Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.